IFNAR — Drug Target
All drugs that target IFNAR — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Phase 3 pipeline (9)
- Rebif New Formulation Titrated · EMD Serono · Interferon · Immunology
Rebif New Formulation Titrated is an interferon beta-1a formulation used to treat multiple sclerosis. - Peginterferon α2b · University of Jena · Interferon · Infectious Diseases
Peginterferon α2b works by stimulating the body's immune system to fight viral infections. - albumin interferon alfa-2b · Human Genome Sciences Inc. · Interferon · Oncology
Albumin interferon alfa-2b is a recombinant form of interferon alfa-2b fused to human albumin, which is used to enhance its half-life and therapeutic effects. - Rebif New Formulation Non Titrated · EMD Serono · Interferon · Immunology
Rebif New Formulation Non Titrated is an interferon beta-1a formulation used to treat multiple sclerosis. - PEG-IFNa 2a · IRCCS San Raffaele · Interferon · Oncology
PEG-IFNa 2a is a pegylated form of interferon alpha-2a, which works by stimulating the body's immune system to fight viral infections and cancer cells. - SNG001 · Synairgen Research Ltd. · Interferon · Respiratory
SNG001 is an inhaled interferon beta-1a, which works by stimulating the body's immune response to fight off respiratory viruses. - interferon-a-2a · Hoffmann-La Roche · Interferon · Oncology
Interferon-alpha-2a works by stimulating the body's immune system to fight viral infections and cancer. - Rebif® new formulation (RNF) · EMD Serono Research & Development Institute, Inc. · Interferon · Immunology
Rebif new formulation (RNF) is an interferon beta-1a used to treat multiple sclerosis. - Pegylated interferon beta-1a · Cinnagen · Interferon · Immunology
Pegylated interferon beta-1a works by stimulating the body's immune system to fight multiple sclerosis.